123 related articles for article (PubMed ID: 19638097)
1. Education and Imaging. Hepatobiliary and pancreatic: spontaneous regression of hepatocellular cancer demonstrated by contrast-enhanced ultrasonography.
Nishijima N; Marusawa H; Kita R; Osaki Y; Chiba T
J Gastroenterol Hepatol; 2009 Jun; 24(6):1153. PubMed ID: 19638097
[No Abstract] [Full Text] [Related]
2. Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma.
Kudo M; Hatanaka K; Kumada T; Toyoda H; Tada T
Am J Gastroenterol; 2011 Feb; 106(2):368-70. PubMed ID: 21301463
[No Abstract] [Full Text] [Related]
3. New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation.
Hiraoka A; Hiasa Y; Onji M; Michitaka K
J Gastroenterol Hepatol; 2011 Apr; 26(4):616-8. PubMed ID: 21418298
[No Abstract] [Full Text] [Related]
4. Contrast-enhanced ultrasound techniques for guiding and assessing response to locoregional treatments for hepatocellular carcinoma.
Andreana L; Kudo M; Hatanaka K; Chung H; Minami Y; Maekawa K; Ruggiero G
Oncology; 2010 Jul; 78 Suppl 1():68-77. PubMed ID: 20616587
[TBL] [Abstract][Full Text] [Related]
5. Assessment of irreversible electroporation ablation zone using Kupffer-phase contrast-enhanced ultrasound images with Sonazoid.
Sugimoto K; Moriyasu F; Yoshiyuki K; Imai Y
J Med Ultrason (2001); 2014 Oct; 41(4):531-2. PubMed ID: 27278039
[No Abstract] [Full Text] [Related]
6. [Super para magnetic iron oxide--Feridex].
Ohtomo K
Nihon Rinsho; 2001 Oct; 59 Suppl 6():319-22. PubMed ID: 11761965
[No Abstract] [Full Text] [Related]
7. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma.
Hatanaka K; Chung H; Kudo M; Haji S; Minami Y; Maekawa K; Hayaishi S; Nagai T; Takita M; Kudo K; Ueda T; Tatsumi C; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Ueshima K
Oncology; 2010 Jul; 78 Suppl 1():53-9. PubMed ID: 20616585
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K
Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532
[TBL] [Abstract][Full Text] [Related]
12. Best cases from the AFIP: fibrolamellar hepatocellular carcinoma.
Smith MT; Blatt ER; Jedlicka P; Strain JD; Fenton LZ
Radiographics; 2008; 28(2):609-13. PubMed ID: 18349461
[No Abstract] [Full Text] [Related]
13. [Contrast-enhanced ultrasonography in the diagnosis of hepatocellular carcinoma].
Forner A; Bruix J
Radiologia; 2013; 55(2):173-4. PubMed ID: 23228630
[No Abstract] [Full Text] [Related]
14. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
Jung G; Poll L; Cohnen M; Saleh A; Vogler H; Wettstein M; Willers R; Mödder U; Koch JA
Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced sonography of a hepatocellular carcinoma undergoing spontaneous necrosis.
Giannetti A; Corsetti M; Quaranta S; Franci L
J Clin Ultrasound; 2008 Oct; 36(8):492-6. PubMed ID: 18663752
[TBL] [Abstract][Full Text] [Related]
17. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K
Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272
[TBL] [Abstract][Full Text] [Related]
18. [Significance of contrast enhanced intraoperative ultrasound with Sonazoid for liver metastases from colorectal cancer].
Mitsunori Y; Kudo A; Nakamura N; Tanaka S; Arii S
Nihon Rinsho; 2011 Apr; 69 Suppl 3():320-4. PubMed ID: 22213977
[No Abstract] [Full Text] [Related]
19. Some unusual complications of malignancies: case 1. Spontaneous rupture of hepatocellular carcinoma demonstrated by contrast-enhanced sonography.
Chou YH; Chiou HJ; Tiu CM; Chen JD; Hung GS; Chiang JH
J Clin Oncol; 2002 Oct; 20(19):4108-11. PubMed ID: 12351607
[No Abstract] [Full Text] [Related]
20. Three-dimensional staining of liver segments with an ultrasound contrast agent as an aid to anatomic liver resection.
Shindoh J; Seyama Y; Umekita N
J Am Coll Surg; 2012 Aug; 215(2):e5-10. PubMed ID: 22683072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
